Primary low-risk trabeculectomy augmented with low-dose mitomycin-C

Abstract

Our data suggest that a primary trabeculectomy augmented with a low dose of MMC is a safe and effective procedure for IOP reduction in patients with a low risk of trabeculectomy failure.